136 related articles for article (PubMed ID: 3495682)
1. Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative.
Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Shibata K; Ohta H; Shimazoe T; Kawamoto H
Jpn J Pharmacol; 1987 Mar; 43(3):309-26. PubMed ID: 3495682
[TBL] [Abstract][Full Text] [Related]
2. Behavioral pharmacology of zopiclone.
Ueki S
Sleep; 1987; 10 Suppl 1():1-6. PubMed ID: 2894069
[TBL] [Abstract][Full Text] [Related]
3. [Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative].
Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Shibata K; Oota H; Nakanishi H; Kiyota Y
Fukuoka Igaku Zasshi; 1983 Aug; 74(8):550-67. PubMed ID: 6686589
[No Abstract] [Full Text] [Related]
4. [Behavioral and electroencephalographic effects of lormetazepam].
Ueki S; Watanabe S; Fujiwara M; Yamamoto T; Shibata S; Shibata K; Ohta H; Sakurai Y; Iwasaki K; Liou SY
Nihon Yakurigaku Zasshi; 1985 Aug; 86(2):145-63. PubMed ID: 2865198
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)].
Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Tazoe N; Shibata S; Shibata K; Ohta H; Kawahara K; Takano M; Suwandi D; Lee SC; Liou SY
Nihon Yakurigaku Zasshi; 1981 May; 77(5):483-509. PubMed ID: 7197658
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of brotizolam, a new thienotriazolodiazepine derivative.
Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K
Jpn J Pharmacol; 1984 Jul; 35(3):287-99. PubMed ID: 6541265
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies on zopiclone.
Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
Pharmacology; 1983; 27 Suppl 2():46-58. PubMed ID: 6142468
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies on zopiclone.
Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
Int Pharmacopsychiatry; 1982; 17 Suppl 2():46-58. PubMed ID: 6145682
[TBL] [Abstract][Full Text] [Related]
9. [Behavioral effects of ethyl loflazepate and its metabolites].
Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K; Ohta H; Ikeda K; Kiyota Y; Sato Y
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):395-409. PubMed ID: 6142848
[TBL] [Abstract][Full Text] [Related]
10. [Electroencephalographic study of Sch 161 (quazepam), a new benzodiazepine hypnotic, in rats and rabbits].
Kawasaki H; Urabe M; Nuki C; Yamamoto R; Takasaki K; Ohno H
Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):221-38. PubMed ID: 3428780
[TBL] [Abstract][Full Text] [Related]
11. Behavioral analysis of zopiclone on the basis of their discriminative stimulus properties in the rat.
Yamamoto T; Kumasaka Y; Ueki S
Jpn J Pharmacol; 1989 Nov; 51(3):337-45. PubMed ID: 2576082
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic studies of central actions of zopiclone: influence on brain monoamines in rats under stressful condition.
Sato K; Hong YL; Yang MS; Shibuya T; Kawamoto H; Kitagawa H
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):204-10. PubMed ID: 2860074
[TBL] [Abstract][Full Text] [Related]
13. A key role of the mammillary body in mediation of the antianxiety action of zopiclone, a cyclopyrrolone derivative.
Yamashita K; Kataoka Y; Miyazaki A; Shibata K; Tominaga K; Ueki S
Jpn J Pharmacol; 1989 Nov; 51(3):438-42. PubMed ID: 2516168
[TBL] [Abstract][Full Text] [Related]
14. Changes in mouse hippocampal EEG characteristics after oral administration of Ro 41-3696, nitrazepam, or zopiclone alone and in combination with ethanol.
Tsuboi M; Tanaka Y; Himori N
Pharmacology; 1994 Nov; 49(5):278-85. PubMed ID: 7862739
[TBL] [Abstract][Full Text] [Related]
15. Effects of zopiclone, triazolam, and nitrazepam on standing steadiness.
Tada K; Sato Y; Sakai T; Ueda N; Kasamo K; Kojima T
Neuropsychobiology; 1994; 29(1):17-22. PubMed ID: 8127419
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivatives (450191-S) (I). Behavioral analysis].
Yamamoto K; Hirose K; Matsushita A; Yoshimura K; Sawada T; Eigyo M; Jyoyama H; Fujita A; Matsubara K; Tsukinoki Y
Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):109-54. PubMed ID: 6149174
[TBL] [Abstract][Full Text] [Related]
17. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone].
Yamamoto T; Shibata S; Teshima K; Inoue Y; Ushio M; Tominaga K; Ohno M; Watanabe S; Ueki S
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):41-52. PubMed ID: 1679740
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clinical efficacy of zopiclone by utilizing two psychophysiological tools in healthy volunteers.
Inanaga K; Tanaka M; Mizuki Y
Pharmacology; 1983; 27 Suppl 2():109-15. PubMed ID: 6669626
[TBL] [Abstract][Full Text] [Related]
19. Effect of zopiclone on the arousal level of healthy volunteers assessed by the averaged photopalpebral reflex.
Tanaka M; Mizuki Y; Isozaki H; Inanaga K
Eur J Clin Pharmacol; 1983; 24(4):469-74. PubMed ID: 6861861
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic.
Kataoka Y; Shibata K; Miyazaki A; Inoue Y; Tominaga K; Koizumi S; Ueki S; Niwa M
Neuropharmacology; 1991 May; 30(5):475-80. PubMed ID: 1865994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
